Clinical Trials Browser

Interventional × Platinum Resistant Ovarian Cancer × Thoracic × Clear all

NCT06517433 2024-07-24

First-in-Human Dose Escalation Study of XMT-1536 in Cancers Likely to Express NaPi2b

Phase 1 Completed

GynecologicThoracic

Platinum Resistant Ovarian Cancer

NCT03319628 2023-11-13

First-in-Human Study of XMT-1536 in Cancers Likely to Express NaPi2b

Phase 1/2 Active not recruiting

GynecologicThoracic

Platinum Resistant Ovarian Cancer